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Abstract
Background: Twin–Twin Transfusion Syndrome (TTTS) is associated with an increased risk of perinatal mortality
and morbidity. Several treatment interventions have been described for TTTS, including fetoscopic laser surgery,
amnioreduction, septostomy, expectant management, and pregnancy termination. Over the last decade, fetoscopic
laser surgery has become the primary treatment. The literature to date reports on many different outcomes, making
it difficult to compare results or combine data from individual studies, limiting the value of research to guide
clinical practice. With the advent and ongoing development of new therapeutic techniques, this is more important
than ever. The development and use of a core outcome set has been proposed to address these issues, prioritising
outcomes important to the key stakeholders, including patients. We aim to produce, disseminate, and implement a
core outcome set for TTTS.
Methods: An international steering group has been established to oversee the development of this core outcome
set. This group includes healthcare professionals, researchers and patients. A systematic review is planned to
identify previously reported outcomes following treatment for TTTS. Following completion, the identified outcomes
will be evaluated by stakeholders using an international, multi-perspective online modified Delphi method to build
consensus on core outcomes. This method encourages the participants towards consensus ‘core’ outcomes. All key
stakeholders will be invited to participate. The steering group will then hold a consensus meeting to discuss results
and form a core outcome set to be introduced and measured. Once core outcomes have been agreed, the next step
will be to determine how they should be measured, disseminated, and implemented within an international context.
Discussion: The development, dissemination, and implementation of a core outcome set in TTTS will enable its use in
future clinical trials, systematic reviews and clinical practice guidelines. This is likely to advance the quality of research
studies and their effective use in order to guide clinical practice and improve patient care, maternal, short-term
perinatal outcomes and long-term neurodevelopmental outcomes.
Trial registration: Core Outcome Measures in Effectiveness Trials (COMET), 921 Registered on July 2016.
International Prospective Register of Systematic Reviews (PROSPERO), CRD42016043999. Registered on 2 August 2016.
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Background
Twin–Twin Transfusion Syndrome (TTTS) is a serious
pathology exclusive to monochorionic twin pregnancies
whereby unbalanced transfusion across the placental vas-
cular anastomoses leads to volume of red cell imbalance
between the twins [1]. The severity of TTTS is most com-
monly classified using the Quintero staging system [1]. In
stage 1, the optimal treatment approach (conservative ver-
sus intervention) remains under debate. In more advanced
stages, intervention is usually recommended to increase
the chance of survival of at least one twin. In severe TTTS
the mortality rate is as high as 90% if untreated [2, 3].
Even with treatment, TTTS is associated with an increased
risk of perinatal morbidity compared with uncomplicated
monochorionic pregnancies, with neurological and cardiac
complications reported, as well as a significant risk of pre-
term birth [2–8].
Several treatment interventions have been described
for TTTS: fetoscopic laser surgery, amnioreduction,
septostomy, expectant management, and termination of
pregnancy. Over the last decade, fetoscopic laser surgery
has become the mainstay of treatment [9]. Several
studies have compared the different techniques and ap-
pear to show that fetoscopic laser surgery is better than
amnioreduction in terms of twin survival and neurode-
velopmental morbidity [10–13]. More recently, com-
parison of the different techniques of fetoscopic laser
ablation has been made, with the Solomon technique
showing improved outcomes compared with selective
ablation [14, 15]. Given the high potential for morbidity
and mortality in TTTS, there is a need for robust guid-
ance on the safest course of management. With the
advent and ongoing development of new therapeutic
techniques, this is more important than ever. The literature to
date reports on many different outcomes, making it difficult
to compare results or combine data from individual studies,
limiting the potential of research to guide clinical practice.
Core outcome sets are agreed, clearly defined mini-
mum sets of outcomes that can be measured in a
standardised manner and reported consistently [16]. Ac-
knowledging that inconsistencies in outcome reporting
can be disruptive to progress in our speciality, 78 editors
of journals of women’s health came together to form a
consortium to support the development, dissemination,
and implementation of core outcome sets [17].
Recently, a core outcome set was developed for the
evaluation of interventions to prevent preterm birth, in-
volving 228 participants from five stakeholder groups.
The stakeholders were from 27 countries. Using the
Delphi method, a core outcome set to be used in future
trials was constructed [18].
Our objective is to produce, disseminate, and imple-
ment a core outcome set for TTTS following the steps
outlined in Fig. 1.
Methods
Prospective registration
This study has been registered with the International
Prospective Register of Systematic Reviews (PROSPERO)
(registration number: CRD42016043999) and The Core
Outcome Measures in Effectiveness Trials (COMET) ini-
tiative (registration number: 921). We will follow guid-
ance set out by the PRISMA Statement for Reporting
Systematic Reviews and Meta-Analyses of Studies that
Evaluate Health Care Interventions [19] for this system-
atic review.
Fig. 1 Stages of developing a core outcome set for Twin–Twin Transfusion Syndrome
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Ethical review
The National Research Ethics Service has advised that
ethical approval is not required for the Delphi survey be-
cause it is considered a service evaluation.
Steering group
An international steering group, including healthcare pro-
fessionals, researchers, and patient representatives, has
been formed to guide the development of this core out-
come set. The steering group was approached and invited
based on their expertise as clinicians and researchers in
TTTS. The steering group has been established to make
decisions regarding the study’s methods, for example de-
termining the scope of the core outcome set and selecting
appropriate consensus methods. Whilst the steering group
will oversee the process, further stakeholders will be in-
volved in the consensus-forming process and anyone, any-
where is welcome to suggest an outcome to be entered
into the consensus process and participate in the priori-
tisation of outcomes.
Scope of the core outcome set
This core outcome set will apply to all therapeutic inter-
ventions for TTTS. The set will not be limited by the
type of intervention, the setting in which it is adminis-
tered, or the gestation at which it is provided. TTTS will
be defined as a monochorionic twin or triplet pregnancy
with oligohydramnios in one amniotic sac and polyhy-
dramnios in the other [1]. We are not seeking to reach
consensus on the standardisation of other aspects of
study design or the definition or staging of TTTS.
Identifying potential core outcomes
We will conduct a systematic review to identify what out-
comes have been reported previously. We will search the
Cochrane Central Register of Controlled Trials (CENTRAL)
as well as EMBASE and MEDLINE from inception to
August 2016 to identify all trials and observational studies
reporting outcomes following intervention for TTTS
using defined MeSH descriptor terms (‘twin twin transfu-
sion syndrome’; ‘TTTS’; ‘interventions’). We will include
all randomised controlled trials and observational
studies that report an outcome following any inter-
vention for TTTS. We will exclude case reports, case
series (n < 3), editorials, and review articles. No data
or language limits will be applied. All studies identi-
fied in the search will be screened from the title and
abstract. The full-text article will be reviewed for all
studies meeting the inclusion criteria and those where
this cannot be decided from the abstract alone. Iden-
tified studies will be reviewed by two reviewers and
any discrepancies resolved by discussion with a third
reviewer. The studies will be assessed using a pre-
defined proforma to gather the following information:
year of study, journal, journal impact factor, study de-
sign, sample size, intervention undertaken, primary and
secondary outcomes, outcome measure instruments, and
funding source. The quality of outcome reporting will be
assessed using the six-point Management of Otitis Media
with Effusion in Cleft Palate scoring system which asks
the following: was a primary outcome stated (one point);
was the primary outcome clearly defined for reproducible
measures (one point); were the secondary outcomes
clearly stated (one point); were the secondary outcomes
clearly defined for reproducible measures (one point); do
the authors explain the choice of outcome (one point);
and are the methods used designed to enhance quality of
measures appropriate (one point) [20]? The systematic re-
view will be reported following the PRISMA statement
criteria [19]. All identified outcomes will be entered into
an outcome inventory and organised into the following
categories: survival outcomes, fetal outcomes, short-term
neonatal outcomes, long-term neonatal outcomes, obstet-
ric outcomes, and surgical/operator outcomes. These out-
comes will be reviewed and discussed by the steering
group with particular emphasis on reducing duplication of
outcomes caused by varying terminologies and grouping
very similar outcomes together in order to make the final
outcome inventory clear and succinct. Following agree-
ment, the inventory will be entered into the modified
Delphi method. The wording of the outcomes will be de-
cided in collaboration with the patient representatives
(Twin and Multiple Births Association (TAMBA)).
Determining core outcomes
The core outcomes will be determined using a modified
Delphi method. The Delphi method is a long-established
tool for achieving a convergence of opinion on a particu-
lar subject by gathering data from respondents with
expert knowledge of that particular subject. It allows
consensus-building by using a series of questionnaires to
extract opinion from participants. Web-based Delphi
tools facilitate international data collection and are
largely considered acceptable to the user [21, 22].
All categories of stakeholder, including health profes-
sionals, researchers, and people with lived experience of
or expertise in TTTS, will be invited to take part. The
recruitment strategy has been designed to ensure that
people with assorted experiences of TTTS from diverse
demographic backgrounds and geographical locations
can be recruited. Recruitment will be facilitated by na-
tional and international patient organisations, including
TAMBA, and national and international professional or-
ganisations, including the Royal College of Obstetricians
and Gynaecologists (RCOG), International Society of
Ultrasound in Obstetrics and Gynaecology (ISUOG),
and International Society of Twin Studies (ISTS), adver-
tising the study within their newsletters, online forums,
Khalil et al. Trials  (2017) 18:325 Page 3 of 7
and social media feeds. Potential participants will be able
to register their interest online and will be sent Delphi
survey instructions written in plain language. When par-
ticipants register to complete the survey, they will
complete a questionnaire recording demographic details,
for example age, ethnic group, and country, and infor-
mation pertaining to their experiences or expertise of
TTTS. Participants who fail to complete the Delphi sur-
vey will be asked about their reasons for dropping out.
We will aim to recruit 18 participants from each stake-
holder group. If this is not achieved, the steering com-
mittee will review the invitation process and re-advertise
prior to commencing the Delphi process. The Delphi
method will follow the following steps.
Round one
All participants will be invited to register with the online
survey and will be allocated a unique identifier to enable
anonymisation of their responses. They will be asked to
score individual outcomes on a nine-point Likert scale
anchored between 1 (labelled ‘of limited importance for
making a decision’) and 9 (labelled ‘critical for making a
decision’). This scale was devised by the Grading of
Recommendations Assessment, Development and Evalu-
ation (GRADE) working group to facilitate the ranking
of outcomes according to their importance and has been
adopted widely by core outcome set developers [23].
There will also be an opportunity for participants to sug-
gest new outcomes in a free text box and these will be
considered by the steering group for incorporation into
the second survey round. The survey will remain open
for 6 weeks with a weekly email reminder for invited
stakeholders to complete the survey.
Round two
Responses from the first round will be disseminated
back anonymously to participants before the second sur-
vey round commences. They will be split into individual
response, stakeholder group response, and total group
response. All outcomes will be carried forwards into the
second round and any additional outcomes suggested by
participants will be included. The mean value for the
total group response will be visible for each outcome in
the second round of the survey and participants will be
asked to re-score the outcome with this new informa-
tion. This repeated reflection and re-scoring promotes
convergence of opinion to form consensus upon core
outcomes [21]. A standardised definition will be applied
to this round’s results, enabling core outcomes to be
identified:
 consensus in (classify as a core outcome)—more
than 70% of participants in each stakeholder group
score outcome ‘critical for decision making’
(score 7–9) and less than 15% of participants in each
stakeholder group score outcome ‘of limited
importance for decision making’ (score 1–3);
 consensus out (do not classify as a core
outcome)—more than 70% of participants in each
stakeholder group score outcome domain ‘of limited
importance for decision making’ (score 1–3) and less
than 15% of participants in each stakeholder group
score outcome domain ‘critical for decision making’
(score 7–9); or
 no consensus (do not classify as a core
outcome)—anything else.
These cut-off values have been used successfully in the
development of core outcome sets previously, including
in a similar population with a similar stakeholder popu-
lation [18, 20]. Defining consensus a priori will reduce
bias that could be incurred with a post-hoc definition to
fit the beliefs of the research team. Results will be ana-
lysed using SPSS 24.0 and displayed as median with
interquartile range in frequency tables and as box plots.
The results will be reviewed by the steering group to de-
cide whether a further round is indicated due to a lack
of consensus being formed.
Stakeholder meeting
The results of the Delphi survey will be discussed in a
consensus meeting where the main objective will be to
address outcomes not reaching consensus after the
Delphi method and approve a final core outcome set for
interventions in TTTS. To ensure unbiased consensus
formation amongst a group of varied participants, the
steering committee will ensure that the meeting is infor-
mal, inclusive, participatory, and values all opinions. For
those outcomes where consensus has not been agreed by
the Delphi method, a final anonymous vote will be made
at the meeting. This will be facilitated using smart-
phone/touchpad technology, allowing all present to vote
anonymously at the same time. Scoring will be done
using the Likert score with the aforementioned defin-
ition of consensus remaining the same. Outcomes that
do not reach consensus at this stage will be rejected and
the final core outcome set agreed.
Failure to agree consensus
We have chosen the Delphi method as a consensus tech-
nique because it offers the advantage of converging large
numbers of opinions without the need for participants
to be together and it allows individuals to decide on
their own without being influenced by others in a group
setting. It is also of relatively low cost. However, the
method does have some limitations: it depends highly
on participant motivation to put thought and effort into
each answer and to see the process through all of the
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rounds. The Delphi method is also fallible where there
are large differences in opinion, and may lead to these
not being investigated fully and, in turn, relevant out-
comes being rejected unnecessarily [24]. As described
earlier, if there are some outcomes that do not meet
consensus, a vote will be cast at the stakeholder meeting.
If it becomes apparent early in the process that the
Delphi method is not working in this scenario, the steer-
ing group will re-evaluate the design of the process and
consider other methods.
Measuring core outcomes
Once the core outcome set has been agreed and estab-
lished it will be necessary to determine how the variables
should be measured. The steering group will consider all
tools for this process including expert opinion as well as
the ongoing work of The Core Outcome Measurement
Instrument Selection (COMIS) project, which aims to
develop validated tools for measuring outcomes [25].
This project has developed guidelines for the selection
of outcome measurement instruments by those develop-
ing core outcome sets, including the identification of
existing outcome measure instruments through a litera-
ture search or systematic review. We will therefore
collect details of outcome measurement instruments as
well as outcomes in our systematic review. Once we
have analysed the range and heterogeneity of outcome
measure instruments we will be better placed to decide
how to proceed further with agreeing on set measures.
The COMIS project emphasises the importance of the
feasibility of any measures agreed and this is an import-
ant consideration for our international stakeholders who
may not all have access to the same resources. We will
aim to outline high-quality outcome measures for each
core outcome and the study will not advocate the use of
a single outcome measure if several high-quality
outcome measures are identified for a single outcome. If
no high-quality outcome measures exist, this will be
acknowledged.
Dissemination and implementation
The steering group will aim to disseminate the core out-
come set as widely and effectively as possible. We will
aim to describe the core outcome set through publica-
tion in a relevant journal as well as presenting to our
peers at meetings. The Core Outcomes in Women’s and
Newborn’s Health (CROWN) initiative is recognised by
RCOG and the Royal Australian and New Zealand
College of Obstetricians and Gynaecologists (RANZCOG),
and we would hope they would endorse the development
of this core outcome set and assist in disseminating our
findings to clinicians worldwide. TAMBA will use their
publicity channels to further share the core outcome set
with both healthcare professionals and patients. With the
CROWN initiative now supported by 78 journals, re-
searchers will have more obligation to engage with the core
outcome set when it comes to planning their studies.
Discussion
The development and implementation of core outcome
sets is likely to be very beneficial to the design and
reporting of clinical studies, systematic reviews, and clin-
ical guidelines. This should ultimately improve clinical
care and patients’ experience. The importance of such
an initiative has been acknowledged by a number of key
national and international organisations.
Improving the selection of the outcome of clinical studies
The Standard Protocol Items: Recommendations for Inter-
ventional Trials (SPIRIT) statement supported by funders
of health research, such as the National Institute of Health
Research (NIHR), recommends the use of core outcome
sets. The use of standard core outcome sets would enhance
comparability of clinical trials and facilitate the conduct of
prospective meta-analyses using individual patient data.
Facilitating the evidence synthesis and reporting of
clinical studies
The CROWN initiative, supported by 78 speciality jour-
nals, including the Cochrane Pregnancy and Childbirth
Group, has resolved to implement core outcome sets.
These journals would expect authors to report the study
results for the core outcomes and draw their conclusions
based on these outcomes rather than non-core or surro-
gate outcomes.
Enhancing the ability to develop robust clinical guideline
The National Institute for Health and Care Excellence
(NICE) supports the use of core outcome sets during
evidence scoping and synthesis [17, 26]. The NICE
methodology for assessment of the quality of the evi-
dence takes into account whether the data of interest
were reported as a core, non-core, or surrogate outcome.
This initiative to improve the quality and consistency of
outcomes investigated and reported by researchers can
in turn lead to the development of guidelines based on
clearer and stronger evidence to help all clinicians offer
the best interventions for their patients.
Developing a network which can support an international
collaboration
The team of involved key stakeholders has the potential
to set up an international network, which could be a po-
tent vehicle for the development of international guide-
lines, registries, and setting research priorities for TTTS.
In the context of TTTS, this could potentially have a
profound impact on morbidity and mortality rates in the
long term.
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Trial status
At the time of manuscript submission, the systematic re-
view process has commenced and strategic planning for the
Delphi method consensus-building exercise is underway.
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